Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new era in the management of Duchenne muscular dystrophy
Rudolf Korinthenberg
Developmental Medicine & Child Neurology (2018) Vol. 61, Iss. 3, pp. 292-297
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The approved gene therapy drugs worldwide: from 1998 to 2019
Cuicui Ma, Zhen-Ling Wang, Ting Xu, et al.
Biotechnology Advances (2019) Vol. 40, pp. 107502-107502
Closed Access | Times Cited: 287
Gene therapy clinical trials, where do we go? An overview
Fatemeh Arabi, Vahid Mansouri, Naser Ahmadbeigi
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113324-113324
Open Access | Times Cited: 160
Antisense Drugs Make Sense for Neurological Diseases
C. Frank Bennett, Holly Kordasiewicz, Don W. Cleveland
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 831-852
Open Access | Times Cited: 84
Recent advances in regenerative medicine strategies for cancer treatment
Vahid Mansouri, Nima Beheshtizadeh, Maliheh Gharibshahian, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111875-111875
Open Access | Times Cited: 72
Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy
Mohsan Iftikhar, Justin Frey, Md.Jasimuddin Shohan, et al.
Pharmacology & Therapeutics (2020) Vol. 220, pp. 107719-107719
Closed Access | Times Cited: 71
Potential Therapeutic Strategies for Skeletal Muscle Atrophy
Li Huang, Ming Li, Chunyan Deng, et al.
Antioxidants (2022) Vol. 12, Iss. 1, pp. 44-44
Open Access | Times Cited: 52
Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies
Omar Sheikh, Toshifumi Yokota
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 2, pp. 167-176
Closed Access | Times Cited: 56
Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: an update
Omar Sheikh, Toshifumi Yokota
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 1-9
Closed Access | Times Cited: 41
Recomendaciones de prescripción de ayudas técnicas en la rehabilitación de pacientes con distrofia muscular de Duchenne
Sandra Milena Castellar-Leones, Edicson Ruiz Ospina, Miguel Ángel Gutiérrez-Ramírez, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-19
Open Access
De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany
Kirsten König, Astrid Pechmann, Simone Thiele, et al.
Orphanet Journal of Rare Diseases (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Electrophysiologic and cardiovascular manifestations of Duchenne and Becker muscular dystrophies
Matthew Hakimi, Tyson Burnham, J. A. Ramsay, et al.
Heart Rhythm (2024)
Open Access | Times Cited: 3
Qualitative and quantitative muscle ultrasound in patients with Duchenne muscular dystrophy: Where do sonographic changes begin?
Katharina Vill, M. Sehri, C Müller, et al.
European Journal of Paediatric Neurology (2020) Vol. 28, pp. 142-150
Closed Access | Times Cited: 20
A Voyage on the Role of Nuclear Factor Kappa B (NF-kB) Signaling Pathway in Duchenne Muscular Dystrophy: An Inherited Muscle Disorder
R.L. Akshaya, Sumithra Mohan, Chitra Vellapandian
Cureus (2024)
Open Access | Times Cited: 2
Multiomics analysis of the mdx/mTR mouse model of Duchenne muscular dystrophy
Douglas W. Van Pelt, Yalda A. Kharaz, Dylan C. Sarver, et al.
Connective Tissue Research (2020) Vol. 62, Iss. 1, pp. 24-39
Open Access | Times Cited: 18
Gene Therapy in the Management of Parkinson’s Disease: Potential of GDNF as a Promising Therapeutic Strategy
Tapan Behl, Ishnoor Kaur, Arun Kumar, et al.
Current Gene Therapy (2020) Vol. 20, Iss. 3, pp. 207-222
Closed Access | Times Cited: 17
Proteomic profiling of fatty acid binding proteins in muscular dystrophy
Paul Dowling, Stephen Gargan, Margit Zweyer, et al.
Expert Review of Proteomics (2020) Vol. 17, Iss. 2, pp. 137-148
Closed Access | Times Cited: 15
Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
Omar Sheikh, Toshifumi Yokota
BioDrugs (2021) Vol. 35, Iss. 4, pp. 389-399
Closed Access | Times Cited: 14
The impact of clinical trial participation on quality of life and psychosocial well-being in children with Duchenne muscular dystrophy and their parents
Sam Geuens, Joanna Willen, C. Antonis, et al.
Neuromuscular Disorders (2023) Vol. 33, Iss. 11, pp. 877-881
Closed Access | Times Cited: 5
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy
Salvo Danilo Lombardo, Maria Sofia Basile, Rosella Ciurleo, et al.
Genes (2021) Vol. 12, Iss. 4, pp. 543-543
Open Access | Times Cited: 9
Performance of Passive Muscle Stiffness in Diagnosis and Assessment of Disease Progression in Duchenne Muscular Dystrophy
Yu H, Xiao Liu, Min Pan, et al.
Ultrasound in Medicine & Biology (2021) Vol. 48, Iss. 3, pp. 414-421
Closed Access | Times Cited: 9
Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy
Marielle G. Contesse, Linda Lowes, Michelle K. White, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266845-e0266845
Open Access | Times Cited: 5
Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy
Yu Xia, Yijie Feng, Lu Xu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 7
Multiomics Analysis of the mdx/mTR Mouse Model of Duchenne Muscular Dystrophy
Douglas W. Van Pelt, Yalda A. Kharaz, Dylan C. Sarver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 5
Identification of two novel insertion abnormal transcripts in two Chinese families affected with Dystrophinopathy
Ying Xu, Tingting Song, Yu Li, et al.
Journal of Clinical Laboratory Analysis (2019) Vol. 34, Iss. 4
Open Access | Times Cited: 5
Home‐based video assessment of ease of movement for patients with Duchenne: Interviews with physical therapists to select movement tasks
Marielle G. Contesse, Jason Hodges, Hannah Staunton, et al.
Physiotherapy Research International (2023) Vol. 28, Iss. 3
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top